HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin-Ming Zhou Selected Research

IMB5046

11/2016A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin-Ming Zhou Research Topics

Disease

3Neoplasms (Cancer)
11/2016 - 01/2008
1Conversion Disorder (Astasia Abasia)
02/2018
1Tuberculosis (Tuberculoses)
11/2017
1Human Influenza (Influenza)
09/2012
1Melanoma (Melanoma, Malignant)
04/2009
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
04/2009
1Colonic Neoplasms (Colon Cancer)
01/2008

Drug/Important Bio-Agent (IBA)

1BismuthIBA
02/2018
1MagnesiumIBA
02/2018
1Protein Kinase InhibitorsIBA
11/2017
1IMB5046IBA
11/2016
1LuciferasesIBA
09/2012
1Pharmaceutical PreparationsIBA
09/2012
1DNA-Directed RNA Polymerases (RNA Polymerase)IBA
09/2012
1LipofectamineIBA
04/2009
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2009
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2009
1Fluorouracil (Carac)FDA LinkGeneric
01/2008
1HexokinaseIBA
01/2008
1Antineoplastic Agents (Antineoplastics)IBA
01/2008

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2016 - 04/2009
1Electrodes (Electrode)
02/2018